Replies to post #213252 on Amarin Corp Plc (AMRN)

[Cupo]

I take those comments as positive. Vascepa is reasonably priced and will impact millions.
There will always be a disconnect with any treatment that a certain % of people can’t afford!
She is right about Harvoni! Price is obscene.
As you pointed out, she specifically mentioned heart care as not being researched enough.